Search for genes - Potential markers of aggressiveness and metastasis for human prostate cancer

Biopolymers and Cell

Volumn 29, Issue 6, 2013, Pages 499-505

  Rosenberg, E E ^a   Prudnikova, T Y ^b   Gerashchenko, G V ^a   Grigorieva, E V ^b   Kashuba, V I ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

Author keywords

Aggressiveness; Androgen independent prostate cancer; Metastasis; Molecular marker

Indexed keywords

INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

AGGRESSIVENESS; ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE CHECKPOINT; CELL CYCLE REGULATION; CELL STRAIN LNCAP; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE CANCER; TUMOR GENE; TUMOR INVASION;

EID: 84893374681     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.000840     Document Type: Article

References (40)

1. Hogle W. Prostate cancer screening, risk, prevention and prognosis // Prostate Cancer / Ed. W. Hogle.-Pittsburgh: Oncology Nursing Society, 2009.-P. 19-33.
2. Gumulec J., Masarik M., Krizkova S., Hlavna M., Babula P., Hrabec R., Rovny A., Masarikova M., Sochor J., Adam V., Eckschlager T., Kizek R. Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers // Neoplasma.-2012.-59, N 2.-P. 191-201.
3. Tai S., Sun Y., Squires J. M., Zhang H., Oh W. K., Liang C. Z., Huang J. PC3 is a cell line characteristic of prostatic small cell carcinoma // Prostate.-2011.-71, N 15.-P. 1668-1679.
4. Geraschenko G. V., Bogatyrova O. O., Rudenko E. E., Kondratov A. G., Gordiyuk V. V., Zgonnyk Y. M., Vozianov O. F., Pavlova T. V., Zabarovsky E. R., Rynditch A. V., Kashuba V. I. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas // Exp. Oncol.-2010.-32, N 2.-P. 71-75.
5. Rudenko E. E., Geraschenko G. V., Lapska Y. V., Bogatyrova O. O., Vozianov S. O., Zgonnyk Y. M., Kashuba V. I. Genetic and epigenetic changes of GPX1 and GPX3 in human clear-cell renal cell carcinoma //Biopolym. Cell.-2013.-29, N5.-P. 395-401.
6. Chiu Y. T., Liu J., Tang K., Wong Y. C., Khanna K. K., LingM. T. Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells // PLoS One.-2012.-7, N 12.-å 51108.
7. Bhatia B., Multani A. S., Patrawala L., Chen X., Calhoun-Davis T., Zhou J., Schroeder L., Schneider-Broussard R., Shen J., Pathak S., Chang S., Tang D. G. Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT // Int. J. Cancer.-2008.-122, N 7.-P.1483-1495.
8. Castro E., Goh C., Olmos D., Saunders E., Leongamornlert D., Tymrakiewicz M., Mahmud N. et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer // J. Clin. Oncol.-2013.-31, N 14.-P. 1748-1757.
9. Chiu Y. T., Han H. Y., Leung S. C., Yuen H. F., Chau C. W., Guo Z., Qiu Y., Chan K. W., Wang X., Wong Y. C., Ling M. T. CDC 25A functions as a novel Ar corepressor in prostate cancer cells // J. Mol. Biol.-2009.-385, N 2.-P. 446-456.
10. Kwon Y. W., Chang I. H., Kim K. D., Kim Y. S., Myung S. C., Kim M. K., Kim T. H. Significance of S100A2 and S100A4 expression in the progression of prostate adenocarcinoma // Korean J. Urol.-2010.-51, N 7.-P. 456-462.
11. Vogelstein B., Lane D., Levine A. J. Surfing the p53 network // Nature.-2000.-408, N 6810.-P. 307-310.
12. Lin Y., Fukuchi J., Hiipakka R. A., Kokontis J. M., Xiang J. Upregulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage // Cell Res.-2007.-17, N 6.-P. 531-536.
13. Huerta-Yepez S., Baritaki S., Baay-Guzman G., Hernandez-Luna M. A., Hernandez-Cueto A., Vega M. I., Bonavida B. Contribution of either YY1 or BclXL-induced inhibition by the NO-do-nor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer // Nitric Oxide.-2013.-29.-P. 17-24.
14. Tang Y. Q., Jaganath I., Manikam R., Sekaran S. D. Phyllanthus suppresses prostate cancer cell, PC-3, proliferation and induces apoptosis through multiple signalling pathways (MAPKs, PI3K/ Akt, NFAB, and hypoxia) // Evid. Based Complement Alternat. Med.-2013.-2013.-P. 609581.
15. Kesarwani P., Mandal R. K., Maheshwari R., Mittal R. D. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer // BJU Int.-2011.-107, N3.-P. 471-476.
16. Long Q., Johnson B. A., Osunkoya A. O., Lai Y. H., Zhou W., Abramovitz M., Xia M., Bouzyk M. B., Nam R. K., Sugar L., Stanimirovic A., Williams D. J., Leyland-Jones B. R., Seth A. K., Petros J. A., Moreno C. S. Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy // Am. J. Pathol.-2011.-179, N 1.-P. 46-54.
17. Zhu Q., Youn H., Tang J., Tawfik O., Dennis K., Terranova P. F., Du J., Raynal P., Thrasher J. B., Li B. Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers // Oncogene.-2008.-27, N 33.-P. 4569-4579.
18. Rostad K., Mannelqvist M., Halvorsen O. J., Oyan A. M., Bo T. H., Stordrange L., Olsen S., Haukaas S. A., Lin B., Hood L., Jonassen I., Akslen L. A., Kalland K. H. ERG upregulation and related ETS transcription factors in prostate cancer // Int. J. Oncol.-2007.-30, N 1.-P. 19-32.
19. DU L., Wu W. A mimic of phosphorylated prolactin induces apoptosis by activating AP-1 and upregulating p21/waf1 in human prostate cancer PC3 cells // Oncol. Lett.-2012.-4, N 5.-P. 1064-1068.
20. Miller S. C., Huang R., Sakamuru S., Shukla S. J., Attene-Ramos M. S., Shinn P., Van Leer D., Leister W., Austin C. P., Xia M. Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action // Biochem. Pharmacol.-2010.-79, N 9.-P. 1272-1280.
21. Chen J., Jiao L., Xu C., Yu Y., Zhang Z., Chang Z., Deng Z., Sun Y. Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression // BMC Cancer.-2012.-12.-P. 593.
22. Varma R. R., Hector S. M., Clark K., Greco W. R., Hawthorn L., Pendyala L. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10 // Oncol. Rep.-2005.-14, N 4.-P. 925-932.
23. Dedhar S., Gray V., Robertson K., Saulnier R. Identification and characterization of a novel high-molecular-weight form of the integrin alpha 3 subunit // Exp. Cell Res.-1992.-203, N 1.-P. 270-275.
24. Tozawa K. Activation of nuclera factor-kappa B and control of the expression of cell adhesion molecules in human prostate cancer cells // Nihon Hinyokika Gakkai Zasshi.-1996.-87, N 9.-P. 1082-1091.
25. Hurt E. M., Chan K., SerratM. A., Thomas S. B., Veenstra T. D., Farrar W. L. Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation // Stem Cells.-2010.-28, N 3.-P. 390-398.
26. Nimmrich I., Erdmann S., Melchers U., Chtarbova S., Finke U., Hentsch S., Hoffmann I., Oertel M., Hoffmann W., Muller O. The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cells // Cancer Lett.-2001.-165, N 1.-P. 71-79.
27. Mustafa N., Martin T. A., Jiang W. G. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells // Exp. Ther. Med.-2011.-2, N 1.-P. 157-162.
28. Wu G. J., Varma V. A., Wu M. W., Wang S. W., Qu P., Yang H., Petros J. A., Lim S. D., Amin M. B. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues // Prostate.-2001.-48, N 4.-P. 305-315.
29. Paulsson J., Sjoblom T., Micke P., Ponten F., Landberg G., Heldin C. H., Bergh J., Brennan D.J., Jirstrom K., Ostman A. Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer // Am. J. Pathol.-2009.-175, N 1.-P. 334-341.
30. Al-Azayzih A., Gao F., Goc A., Somanath P. R. TGFT1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases // Biochem. Biophys. Res. Commun.-2012.-427, N 1.-P. 165-170.
31. Amatangelo M. D., Goodyear S., Varma D., StearnsM. E. c-Myc expression andMEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer // Carcinogenesis.-2012.-33, N 10.-P. 1965-1975.
32. Firlej V., Mathieu J. R., Gilbert C., Lemonnier L., Nakhle J., Gallou-Kabani C., Guarmit B., Morin A., Prevarskaya N., Delongchamps N. B., Cabon F. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors // Cancer Res.-2011.-71, N 24.-P. 7649-7658.
33. Darrington E., Zhong M., Vo B. H., Khan S. A. Vascular endothelial growth factor A, secreted in response to transforming growth factor-c1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells // Asian J. Androl.-2012.-14, N 5.-P. 745-751.
34. Maeda A., Nakashiro K., Hara S., Sasaki T., Miwa Y., Tanji N., Yokoyama M., Hamakawa H., Oyasu R. Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells // Biochem. Biophys. Res. Commun.-2006.-347, N 4.-P. 1158-1165.
35. Bao W., Fu H. J., Jia L. T., Zhang Y., Li W., Jin B. Q., Yao L. B., Chen S. Y., Yang A. G. HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion // Arch. Biochem. Biophys.-2010.-499, N 1-2.-P. 49-55.
36. Cui Y., Niu A., Pestell R., Kumar R., Curran E.M., Liu Y., Fuqua S. A. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells // Mol. Endocrinol.-2006.-20, N 9.-P. 2020-2035.
37. Seifert M., Welter C., Mehraein Y., Seitz G. Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer // J. Pathol.-2005.-205, N5.-P. 623-632.
38. Hagelgans A., Menschikowski M., Fuessel S., Nacke B., Arneth B. M., Wirth M. P., Siegert G. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms // Exp. Mol. Pathol.-2013.-94, N 3.-P. 458-465.
39. Teoh S. S., Whisstock J. C., Bird P. I. Maspin (SERPINB5) is an obligate intracellular serpin // J. Biol. Chem.-2010.-285, N 14.-P. 10862-10869.
40. Eide T., Ramberg H., Glackin C., Tindall D., Tasken K. A. TWIST1, a novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells // Cancer Cell Int.-2013.-13, N1.-P. 4.